4,5,6,7-tetrabromo-2-azabenzimidazole has been researched along with Leukemia, Lymphoblastic, Acute, T Cell in 1 studies
4,5,6,7-tetrabromobenzotriazole: a CK2 kinase inhibitor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Silva, A | 1 |
| Jotta, PY | 1 |
| Silveira, AB | 1 |
| Ribeiro, D | 1 |
| Brandalise, SR | 1 |
| Yunes, JA | 1 |
| Barata, JT | 1 |
1 other study available for 4,5,6,7-tetrabromo-2-azabenzimidazole and Leukemia, Lymphoblastic, Acute, T Cell
| Article | Year |
|---|---|
Regulation of PTEN by CK2 and Notch1 in primary T-cell acute lymphoblastic leukemia: rationale for combined use of CK2- and gamma-secretase inhibitors.
Topics: Amyloid Precursor Protein Secretases; Blotting, Western; Casein Kinase II; Cell Proliferation; Cell | 2010 |